We're now accepting registrations on Spevigo (spesolimab) for patients with Generalised Pustular Psoriasis, and registrations on Sotyktu (deucravacitinib).
Live

Welcome to the BADBIR database

You have been automatically logged out. If you were still working on a database page prior to log out there is a possibility this data was not saved. Please log in again.

Welcome to the BADBIR Database

The University of Manchester Printed by anonymous on 25/04/2024. By printing this page, the user agrees to store this paper securely or destroy it immediately.